Defence lawyers have hailed the Supreme Court's ruling in Dura Pharmaceuticals for restricting securities fraud litigation. William Sullivan and Tracey DeLange, counsel to Dura, argue that the
ruling is also good for the economy
To access our in-house intelligence please request a trial here.
Read this article – and more – for a one-week period.